KBC Group NV Buys 46,392 Shares of Axon Enterprise, Inc $AXON

KBC Group NV boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 342.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 59,947 shares of the biotechnology company’s stock after purchasing an additional 46,392 shares during the period. KBC Group NV’s holdings in Axon Enterprise were worth $34,045,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Stone House Investment Management LLC purchased a new stake in Axon Enterprise in the third quarter worth about $29,000. New Millennium Group LLC purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at about $29,000. Darwin Wealth Management LLC bought a new position in shares of Axon Enterprise during the 2nd quarter valued at approximately $37,000. Root Financial Partners LLC bought a new position in shares of Axon Enterprise during the 3rd quarter valued at approximately $34,000. Finally, Sound Income Strategies LLC increased its holdings in Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after acquiring an additional 44 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on AXON shares. Needham & Company LLC lowered their price target on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating on the stock in a report on Friday, February 20th. Royal Bank Of Canada reduced their price objective on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research note on Wednesday, February 25th. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Finally, Citizens Jmp reaffirmed a “market outperform” rating and issued a $825.00 target price on shares of Axon Enterprise in a report on Monday. Sixteen investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $749.63.

Axon Enterprise Stock Down 2.3%

Shares of AXON opened at $393.08 on Friday. The business’s 50 day moving average is $460.29 and its 200 day moving average is $557.38. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company has a market capitalization of $31.60 billion, a PE ratio of 258.61, a price-to-earnings-growth ratio of 8.58 and a beta of 1.61.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same period in the prior year, the company posted $2.08 EPS. The firm’s revenue for the quarter was up 38.5% compared to the same quarter last year. Research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Transactions at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the transaction, the chief executive officer owned 3,090,997 shares in the company, valued at approximately $1,546,240,339.28. This represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $573.45, for a total transaction of $860,175.00. Following the transaction, the chief accounting officer directly owned 12,240 shares of the company’s stock, valued at $7,019,028. The trade was a 10.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 13,855 shares of company stock valued at $7,109,828. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.